Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences. Unidade: FCF
Assunto: ESCLEROSE MÚLTIPLA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARDOSO, Laila Guimarães e RIBEIRO, Adalton Guimarães e KANO, Eunice Kazue. Progressive multifocal leukoencephalopaty associated to natalizumab: the importance of MRI based diagnosis in asymptomatic cases. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 27 abr. 2024. , 2014APA
Cardoso, L. G., Ribeiro, A. G., & Kano, E. K. (2014). Progressive multifocal leukoencephalopaty associated to natalizumab: the importance of MRI based diagnosis in asymptomatic cases. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Cardoso LG, Ribeiro AG, Kano EK. Progressive multifocal leukoencephalopaty associated to natalizumab: the importance of MRI based diagnosis in asymptomatic cases. Brazilian Journal of Pharmaceutical Sciences. 2014 ; 50 32 res. FCF060.[citado 2024 abr. 27 ]Vancouver
Cardoso LG, Ribeiro AG, Kano EK. Progressive multifocal leukoencephalopaty associated to natalizumab: the importance of MRI based diagnosis in asymptomatic cases. Brazilian Journal of Pharmaceutical Sciences. 2014 ; 50 32 res. FCF060.[citado 2024 abr. 27 ]